Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

177 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Identification of IG-clonality status as a pre-treatment predictor for mortality in patients with immunodeficiency-associated Epstein-Barr virus-related lymphoproliferative disorders.
van der Velden WJ, Nissen L, van Rijn M, Rijntjes J, de Haan A, Venkatraman L, Catherwood M, Liu H, El-Daly H, van de Laar L, Craenmehr MH, van Krieken JH, Stevens WB, Groenen PJ. van der Velden WJ, et al. Among authors: groenen pj. Haematologica. 2015 Apr;100(4):e152-4. doi: 10.3324/haematol.2014.116780. Epub 2014 Dec 19. Haematologica. 2015. PMID: 25527569 Free PMC article. No abstract available.
Immunohistochemical differentiation between follicular lymphoma and nodal marginal zone lymphoma--combined performance of multiple markers.
van den Brand M, Mathijssen JJ, Garcia-Garcia M, Hebeda KM, Groenen PJ, Falini B, Serrano S, van Krieken JH. van den Brand M, et al. Among authors: groenen pj. Haematologica. 2015 Sep;100(9):e358-60. doi: 10.3324/haematol.2014.120956. Epub 2015 Jun 11. Haematologica. 2015. PMID: 26069292 Free PMC article. No abstract available.
Clinical features of patients with nodal marginal zone lymphoma compared to follicular lymphoma: similar presentation, but differences in prognostic factors and rate of transformation.
van den Brand M, van der Velden WJ, Diets IJ, Ector GI, de Haan AF, Stevens WB, Hebeda KM, Groenen PJ, van Krieken HJ. van den Brand M, et al. Among authors: groenen pj. Leuk Lymphoma. 2016 Jul;57(7):1649-56. doi: 10.3109/10428194.2015.1106535. Epub 2015 Dec 23. Leuk Lymphoma. 2016. PMID: 26694256
177 results